IndraLab

Statements

Glioma increases the amount of RAET1E. 1 / 1

| 1

reach

"Treatment of glioma cells with the catalytic LSD1 inhibitors tranylcypromine (TCP) or GSK LSD1 was able to increase MICB and ULBP4 expression, enhancing human NK-cell mediated lysis of the target cells (137)."

37090711

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Glioma increases the amount of RAET1E. 1 / 1

INDRA sources:

Databases

Reading